Select Medical's stock has seen a significant surge following RBC's decision to raise its price target for the company. This positive adjustment reflects RBC's confidence in Select Medical's growth potential and market performance, which is encouraging for investors. Such developments can lead to increased investor interest and potentially higher stock prices, making it a noteworthy event in the financial landscape.

RBC Capital has raised its price target for Select Medical's stock to $20, citing recent regulatory relief as a key factor. This adjustment reflects growing confidence in the company's future performance and highlights the positive impact of regulatory changes on its operations. Investors may see this as a promising sign for Select Medical's growth potential.